Gilead Sciences Sets Up As A Beautiful Short
The biotech sector is in one of the biggest bubbles since the Dot.com era. Some of the largest biotechnology companies in the world have doubled and tripled their size in the last year. One such stock is Gilead Sciences, Inc. (NASDAQ:GILD). The stock is hovering up 100% from its lows a year ago and has a market cap of $128 billion.
Reasons For The Short:
1. Biotech sector in a bubble with cracks emerging.
2. Gildead Sciences is up 100% in the last year with no significant pull backs.
3. The valuation is unsustainable for Gilead Sciences in the near term.
4. The stock has not been able to push through the technically important $85.00 level.
Overall, this sector has been an area where money has continued to flow. The music appears like it is coming to a stop. Gilead should have a pull back to $76.00 then $65,00.